Standard BioTools Inc (LAB)
2.40
-0.01
(-0.41%)
USD |
NASDAQ |
May 10, 16:00
2.405
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Debt to Equity Ratio: -0.429 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | -0.429 |
September 30, 2023 | -0.4904 |
June 30, 2023 | -0.5754 |
March 31, 2023 | -0.6697 |
December 31, 2022 | -0.7965 |
September 30, 2022 | -1.031 |
June 30, 2022 | -1.723 |
March 31, 2022 | 4.524 |
December 31, 2021 | 0.7511 |
September 30, 2021 | 0.6447 |
June 30, 2021 | 0.4929 |
March 31, 2021 | 0.4379 |
December 31, 2020 | 0.39 |
September 30, 2020 | 0.3561 |
June 30, 2020 | 0.407 |
March 31, 2020 | 0.3811 |
December 31, 2019 | 0.3504 |
September 30, 2019 | 0.3066 |
June 30, 2019 | 0.2887 |
March 31, 2019 | 0.2731 |
December 31, 2018 | 2.386 |
September 30, 2018 | 7.556 |
June 30, 2018 | 4.787 |
March 31, 2018 | 3.380 |
December 31, 2017 | 6.311 |
Date | Value |
---|---|
September 30, 2017 | 4.995 |
June 30, 2017 | 8.150 |
March 31, 2017 | 5.065 |
December 31, 2016 | 3.662 |
September 30, 2016 | 2.867 |
June 30, 2016 | 2.312 |
March 31, 2016 | 1.968 |
December 31, 2015 | 1.694 |
September 30, 2015 | 1.576 |
June 30, 2015 | 1.468 |
March 31, 2015 | 1.372 |
December 31, 2014 | 1.299 |
September 30, 2014 | 1.264 |
June 30, 2014 | 1.207 |
March 31, 2014 | 1.166 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.0183 |
June 30, 2012 | 0.0961 |
March 31, 2012 | 0.1222 |
December 31, 2011 | 0.1782 |
September 30, 2011 | 0.1959 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.723
Minimum
Jun 2022
4.524
Maximum
Mar 2022
0.1902
Average
0.3504
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Bruker Corp | 0.974 |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5175 |
Bionano Genomics Inc | 0.3513 |
Akoya Biosciences Inc | 1.400 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 323.07M |
Total Liabilities (Quarterly) | 471.12M |
Shareholders Equity (Quarterly) | -148.05M |
Current Ratio | 1.447 |
Net Debt Paydown Yield | 0.14% |